January 26, 2017 1:12pm

 

Pricings started up, went down, stayed down at the mid-day and continues round and round

 

 

I answer one question; in which company should investors put, keep and commit their money!

… As I focus on the facts in evidence …

 

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.

 

 

U.S. equities traded mostly flat on Thursday at the mid-day after hitting new record highs, as investors digested several key earnings reports.

The NASDAQ is DOWN at the mid-day -0.37 or -0.01% to 5656.32 and the DOW is UP +33.91 or +0.17% to 20,102.42.

 

 

A day in the life of the stem, cell, gene and regenerative therapy (SCGT & RT) sector – the advance/decline line scenario of our 43 covered companies:   

  • The open was positive with an A/DL of 24/15 and 4 flats;
  • 10:30 am fell negative with an A/DL of 8/31 and 4 flats;
  • 11:30 am moved but, still negative with an A/DL of 20/22 and 1 flat;
  • The mid-day stayed negative with an A/DL of 18/24 and 1 flat;

 

 

Henry’omics:

From the mid-day’s investor’s letter, “Even if we forget the sector’s pricing fluctuations and the performances of “our” universe; money seems to move without a true direction”

 

As I stated, “As I have said, follow the share pricing!”

 

Investor are about to reach the beginning of the Q4 financial results season, notice I did NOT say earnings period.

  • The deluge of releases in the next two weeks will confirm whether the final three months of 2016 marked a share pricing decline and increased spending and the biggest issue – LOW cash balances …

This hurdle compounds the difficulty for managements to define their focus for the New Year and provide guidance and a forecast of ANY corporate ambition

 

Financial results will be producing some unusual and confusing releases that will … certainly make portfoilio reading  difficult for many investors.

 

 

Indexes, the ebb and flow:

  • The iShares Russell 2000 (IWM) indicated a positive +0.09% in the pre- open and was at the mid-day  DOWN -0.37%%.
  • The iShares NASDAQ Biotechnology (IBB) indicated a positive +0.10% in the pre-open and was at the mid-day UP +0.36%

 

 

Review my fear gauge or the CBOE Volatility Index (VIX):

  • Thursday traded near 10.9;
  • Wednesday traded near 10.8;
  • Tuesday traded near 11.4;
  • Monday traded near 12.2;
  • Friday traded near 12.3;
  • Last Thursday traded near 12.4;